Vifor Pharma
Vifor Pharma, Inc.
100 Cardinal Way
Redwood City, CA 94063
Phone: (650) 421-9500Website: https://www.viforpharma.com/en-usCareers: www.viforpharma.com/en-us/careers
Latest news
- FDA Approves Supplemental New Drug Application for Veltassa Removing Boxed Warning Regarding Drug-Drug Interactions
27 November 2016 - FDA Approves Veltassa (patiromer) for Hyperkalemia
21 October 2015 - Relypsa Announces October 21, 2015 as PDUFA Date for NDA for Patiromer for Oral Suspension
5 January 2015 - Relypsa Announces FDA Acceptance of New Drug Application for Patiromer for Oral Suspension to Treat Hyperkalemia
15 December 2014 - Relypsa Submits NDA for Patiromer for Oral Suspension to Treat Hyperkalemia
22 October 2014
Drugs Associated with Vifor Pharma, Inc.
Vifor Pharma, Inc. manufactures, markets and/or distributes 1 drug in the United States. Medications listed here may also be marketed under different names in different countries. Non-US country and region specific information is not available on this page.
| Brand/Generic Name | Reviews | Rating |
|---|---|---|
|
Veltassa
Generic name: patiromer Drug class: cation exchange resins |
10 reviews | 6.2 / 10 |
| For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). | ||
